Effect of sodium-glucose co-transporter-2 inhibitor on estimated plasma volume in a patient with heart failure with reduced ejection fraction and a patient with heart failure with preserved ejection fraction
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023884%3A_____%2F24%3A00009826" target="_blank" >RIV/00023884:_____/24:00009826 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11120/24:43927331
Result on the web
<a href="https://pubmed.ncbi.nlm.nih.gov/39031990/" target="_blank" >https://pubmed.ncbi.nlm.nih.gov/39031990/</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/clc.24303" target="_blank" >10.1002/clc.24303</a>
Alternative languages
Result language
angličtina
Original language name
Effect of sodium-glucose co-transporter-2 inhibitor on estimated plasma volume in a patient with heart failure with reduced ejection fraction and a patient with heart failure with preserved ejection fraction
Original language description
Background: The increased diuresis after sodium-glucose cotransporter 2 inhibitor (SGLT2i) was associated with a reduction of the estimated plasma volume in type 2 diabetic patients. Hypothesis: We hypothesised that the effect of SGLT2i on estimated plasma volume may be monitored by the change of biomarkers of hemoconcentration. Patients and methods: We analyzed the long term effect of SGLT2i empagliflozin on the estimated plasma volume as assessed by biomarkers of hemoconcentration in a non-diabetic patient with heart failure and reduced ejection fraction (HFrEF) and a non-diabetic pateint with heart failure and preserved ejection fraction (HFpEF). The estimated plasma volume (ePV) was calculated from hemoglobin and hematocrit levels by Duarte formula and ePV change was calculated vy Strauss formula. Results: The ePV change was – 22.56 % between baseline and one month,and – 37.60 % between baseline and 12 months follow-up in a patient with HFrEF, and – 6.18 % and – 16.40 % in a patient with HFpEF respectively. Conclusion: The effect of SGLT2i on estimated plasma volume in patients with heart failure may be monitored by biomarkers of hemoconcentration.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Clinical Cardiology
ISSN
0160-9289
e-ISSN
—
Volume of the periodical
47
Issue of the periodical within the volume
7
Country of publishing house
US - UNITED STATES
Number of pages
5
Pages from-to
—
UT code for WoS article
001272213800001
EID of the result in the Scopus database
2-s2.0-85198912331